Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA)

Initial moderator analyses in the Multimodal Treatment Study of Children with ADHD (MTA) suggested that child anxiety ascertained by parent report on the Diagnostic Interview Schedule for Children 2.3 (DISC Anxiety) differentially moderated the outcome of treatment. Left unanswered were questions regarding the nature of DISC Anxiety, the impact of comorbid conduct problems on the moderating effect of DISC Anxiety, and the clinical significance of DISC Anxiety as a moderator of treatment outcome. Thirty-three percent of MTA subjects met DSM-III-R criteria for an anxiety disorder excluding simple phobias. Of these, two-thirds also met DSM-III-R criteria for comorbid oppositional-defiant or conduct disorder whereas one-third did not, yielding an odds ratio of approximately two for DISC Anxiety, given conduct problems. In this context, exploratory analyses of baseline data suggest that DISC Anxiety may reflect parental attributions regarding child negative affectivity and associated behavior problems (unlike fearfulness), particularly in the area of social interactions, another core component of anxiety that is more typically associated with phobic symptoms. Analyses using hierarchical linear modeling (HLM) indicate that the moderating effect of DISC Anxiety continues to favor the inclusion of psychosocial treatment for anxious ADHD children irrespective of the presence or absence of comorbid conduct problems. This effect, which is clinically meaningful, is confined primarily to parent-reported outcomes involving disruptive behavior, internalizing symptoms, and inattention; and is generally stronger for combined than unimodal treatment. Contravening earlier studies, no adverse effect of anxiety on medication response for core ADHD or other outcomes in anxious or nonanxious ADHD children was demonstrated. When treating ADHD, it is important to search for comorbid anxiety and negative affectivity and to adjust treatment strategies accordingly.

[1]  J. Parker,et al.  Test-retest reliability of the Multidimensional Anxiety Scale for Children. , 1999, Journal of anxiety disorders.

[2]  M Davies,et al.  The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  H. Kraemer,et al.  A strategy to use soft data effectively in randomized controlled clinical trials. , 1989, Journal of consulting and clinical psychology.

[4]  R. Tannock,et al.  Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  S. Compton,et al.  Social phobia and separation anxiety symptoms in community and clinical samples of children and adolescents. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[6]  D. Hedeker,et al.  Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. , 1988, Psychopharmacology bulletin.

[7]  J. Swanson,et al.  Comprehensive assessment of childhood Attention-Deficit Hyperactivity Disorder in the context of a multisite, multimodal clinical trial , 1997 .

[8]  J. Swanson,et al.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  J. Swanson,et al.  NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution , 1997 .

[10]  K. Carroll,et al.  Now You See It, Now You Don't A Comparison of Traditional Versus Random-Effects Regression Models in the Analysis of Longitudinal Follow-Up Data From a Clinical Trial , 1997 .

[11]  J. Swanson,et al.  Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. , 1999, Archives of general psychiatry.

[12]  S. Pliszka.  Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. , 1998, The Journal of clinical psychiatry.

[13]  P. Frick,et al.  Assessment of childhood anxiety using structured interviews: Patterns of agreement among informants and association with maternal anxiety. , 1994 .

[14]  S. Pliszka,et al.  Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. , 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.

[16]  P. Lewinsohn,et al.  Correspondence between adolescent report and parent report of psychiatric diagnostic data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  B. Everitt,et al.  Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour , 1987, Psychological Medicine.

[18]  S. Pliszka.  Effect of anxiety on cognition, behavior, and stimulant response in ADHD. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[19]  W. Silverman,et al.  The Anxiety Disorders Interview Schedule for Children. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  S. Lilienfeld.  The relation of anxiety sensitivity to higher and lower order personality dimensions: implications for the etiology of panic attacks. , 1997, Journal of abnormal psychology.

[21]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[22]  F. Gresham.  Teacher-Rated Social Skills of Mainstreamed Mildly Handicapped and Nonhandicapped Children. , 1987 .

[23]  J. Parker,et al.  The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[24]  R. Baldessarini,et al.  A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  R. Tannock,et al.  Response to methylphenidate in children with ADHD and comorbid anxiety. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  B. Tonge,et al.  Attention Deficit Hyperactivity Disorder: Anxiety Phenomena in Children Treated with Psychostimulant Medication for 6 Months or More , 1999, The Australian and New Zealand journal of psychiatry.

[27]  H. Kraemer,et al.  ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  D. Cantwell,et al.  Comorbidity in ADHD: implications for research, practice, and DSM-V. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  J. Swanson,et al.  Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. , 1999, Pediatric clinics of North America.

[30]  S. Lilienfeld,et al.  The Association between Anxiety and Psychopathy Dimensions in Children , 1999, Journal of abnormal child psychology.

[31]  D. Cicchetti,et al.  Developmental psychopathology and disorders of affect , 1995 .

[32]  R. Rapee,et al.  Reliability of the DSM-III-R childhood anxiety disorders using structured interview: interrater and parent-child agreement. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  G. Solomons,et al.  Hyperkinetic impulse disorder in children's behavior problems. , 1957, Psychosomatic medicine.

[34]  S. Hinshaw,et al.  The Multidimensional Anxiety Scale for Children (MASC): Confirmatory factor analysis in a pediatric ADHD sample , 1999 .

[35]  S. Lilienfeld.  Conceptual problems in the assessment of psychopathy , 1994 .

[36]  G. Holmbeck.  Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators : examples from the child-clinical and pediatric psychology literatures , 1997 .

[37]  J. Swanson,et al.  Psychosocial Treatment Strategies in the MTA Study: Rationale, Methods, and Critical Issues in Design and Implementation , 2000, Journal of abnormal child psychology.